Library
5-EAPB
Extremely limited human data; doses above 140 mg strongly discouraged. Fatal case reported at ~500 mg combined with MDAI (blood concentration 6.45 mg/L). Acts as monoamine releasing agent with 5-HT2A/5-HT2B agonist properties; chronic use may risk valvular heart disease via 5-HT2B activation. Described as less stimulating than MDMA with predominantly serotonergic effects. Always test substance purity; reagents produce MDMA-like reactions.
Classification
- Chemical: Amphetamine
- Chemical: Benzofuran
- Chemical: Phenethylamine
- Psychoactive: Entactogen
- Psychoactive: Psychedelic
- Psychoactive: Stimulant
- Tag: Empathogen
- Tag: Habit-Forming
- Tag: Research-Chemical
- Tag: Substituted amphetamine
Effects
- Stimulation
- Pupil Dilation
- Teeth Grinding
- Temperature Regulation Suppression
- Increased Heart Rate
- Difficulty Urinating
- Cognitive Euphoria
- Empathy Affection And Sociability Enhancement
- Anxiety
- Euphoria
- Increased Sociability
- Mood Lift
- Increased Music Appreciation
- Tactile Enhancement
- Color Enhancement
- Increased Sexuality
- Visual And Audiotory Hallucinations Itchiness
- Closed Eye Visuals
Routes of Administration
Oral
Dosage
- Threshold: 20–35 mg
- Light: 40-60 mg
- Common: 60-100 mg
- Strong: 100-150 mg
- Heavy: 150+ mg
Duration
- Onset: 0.5-1 h
- Comeup: 0.5-1 h
- Peak: 1.5-3 h
- Offset: 1-2 h
- After Effects: 6-12 h
- Total Duration: 4-8 h
Insufflated
Dosage
- Threshold: 10–20 mg
- Light: 30-40 mg
- Common: 40-60 mg
- Strong: 60-100 mg
- Heavy: 100 mg
Duration
- Onset: 0.08-0.17 h
- Comeup: 0.25-0.5 h
- Peak: 0.75-2 h
- Offset: 2-3.5 h
- After Effects: 3.5-10 h
- Total Duration: 3-6 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.